Followers | 16 |
Posts | 6778 |
Boards Moderated | 1 |
Alias Born | 06/06/2007 |
Monday, February 06, 2017 9:06:16 AM
current levels given our outlook for cannabis-based product demand, a balance sheet that supports rapid capacity expansion, and
its vertically integrated model led by strong management. The Company is currently completing its Phase 2 expansion that should
triple production capability to 2,100 kg, with commissioning expected by April 2017. We estimate that EMC has another $40M
available to fund additional expansion to support expected demand from the recreational market. The Company’s pharmaceutical
division, led by Mr. John Stewart (former President/CEO of Purdue Pharma Canada and Purdue Pharma USA), is working to
develop cannabinoid-based formulations, which should help drive market expansion.
https://equity.guru/wp-content/uploads/2017/02/Cannabis_Theme_Report.pdf
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM